These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3283356)

  • 21. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The importance of administration of a series of methylprednisolone minipulses in the treatment of active rheumatoid arthritis].
    Hrncír Z
    Cas Lek Cesk; 1994 Jul; 133(14):440-2. PubMed ID: 8069902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of oral prednisolone and intramuscular methylprednisolone in classical rheumatoid arthritis in out-patients.
    Cochrane G
    Rheumatol Phys Med; 1971 May; 11(2):89-90. PubMed ID: 4931625
    [No Abstract]   [Full Text] [Related]  

  • 25. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone.
    Fan PT; Yu DT; Clements PJ; Fowlston S; Eisman J; Bluestone R
    J Lab Clin Med; 1978 Apr; 91(4):625-34. PubMed ID: 76667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. II. Effects on immune and inflammatory indices in peripheral blood.
    Smith MD; Ahern MJ; Brooks PM; Roberts-Thomson PJ
    J Rheumatol; 1988 Feb; 15(2):233-7. PubMed ID: 3361535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D
    J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
    Furst DE; Lindsley H; Baethge B; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D
    Arthritis Rheum; 1999 Feb; 42(2):357-65. PubMed ID: 10025931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
    Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
    Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial.
    Finckh A; Zufferey P; Schurch MA; Balagué F; Waldburger M; So AK
    Spine (Phila Pa 1976); 2006 Feb; 31(4):377-81. PubMed ID: 16481946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
    Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study.
    Frediani B; Falsetti P; Bisogno S; Baldi F; Acciai C; Filippou G; Bacarelli MR; Filipponi P; Galeazzi M; Marcolongo R
    J Rheumatol; 2004 Jun; 31(6):1083-7. PubMed ID: 15170918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype.
    Youssef P; Roberts-Thomson P; Ahern M; Smith M
    J Rheumatol; 1995 Nov; 22(11):2065-71. PubMed ID: 8596146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?
    Smith MD; Ahern MJ; Roberts-Thomson PJ
    Ann Rheum Dis; 1988 Jan; 47(1):28-33. PubMed ID: 3278694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.